Back
Westlake Corp. 10K Form
Sell
44
WLK
Westlake Corp.
Last Price:
$106.13
Seasonality Move:
2.03%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2023-11-02 | 10Q | WLK/Westlake Corp. Quarterly |
| 2023-08-03 | 10Q | WLK/Westlake Corp. Quarterly |
| 2023-05-04 | 10Q | WLK/Westlake Corp. Quarterly |
| 2022-11-03 | 10Q | WLK/Westlake Corp. Quarterly |
| 2022-08-03 | 10Q | WLK/Westlake Corp. Quarterly |
| 2022-05-04 | 10Q | WLK/Westlake Corp. Quarterly |
Receive WLK News And Ratings
See the #1 stock for the next 7 days that we like better than WLK
WLK Financial Statistics
Sales & Book Value
| Annual Sales: | $11.2B |
|---|---|
| Cash Flow: | $-16M |
| Price / Cash Flow: | 115.86 |
| Annual Sales: | $68.74 |
| Price / Book: | 1.5 |
Profitability
| EPS (TTM): | -11.70380 |
|---|---|
| Net Income (TTM): | $-1.5B |
| Gross Margin: | $689M |
| Return on Equity: | -14.08% |
| Return on Assets: | -7.17% |
Westlake Corp. Earnings Forecast
Key Westlake Corp. Financial Ratios
-
The Gross Profit Margin over the past 27 years for WLK is 6.17%.
-
The Selling, General & Administrative Expenses for WLK have been equal to 8.06% of Gross Profit Margin.
-
The Research & Development expenses have been 0.00% of Revenue.
-
The Net Earning history of WLK is -13.11% of Total Revenues.
-
Per Share Earnings over the last 27 years have been positive in 13 years.
Westlake Corp. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NYSE |
|---|---|
| Industry: | Chemicals |
| Sector: | Materials |
| Current Symbol: | WLK |
| CUSIP: | 960413 |
| Website: | westlake.com |
Debt
| Debt-to-Equity Ratio: | 0.73 |
|---|---|
| Current Ratio: | 2.24 |
| Quick Ratio: | 1.51 |
Price-to-Earnings
| Trailing P/E Ratio: | 20.06 |
|---|---|
| Forward P/E Ratio: | 33.97 |
WLK Technical Analysis vs Fundamental Analysis
Sell
44
Westlake Corp. (WLK)
is a Sell
Is Westlake Corp. a Buy or a Sell?
-
Westlake Corp. stock is rated a SellThe current Westlake Corp. [WLK] share price is $102.92. The Score for WLK is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.